Market Tracker

11/21 12:36pm ET

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

9.62
Delayed Data
As of 12:21pm ET
 -0.08 / -0.82%
Today’s Change
8.07
Today|||52-Week Range
18.00
-30.44%
Year-to-Date

Today’s Trading

Previous close9.70
Today’s open9.71
Day’s range9.52 - 9.78
Volume218,874
Average volume (3 months)757,774
Market cap$1.0B
Dividend yield--
Data as of 12:21pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-1.01%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book6.43

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.85+2.22%
PCRXPacira Pharmaceutica...-0.55-1.30%
INVAInnoviva Inc+0.09+0.68%
MYOKMyoKardia Inc-0.10-0.27%
Data as of 12:32pm ET, 11/21/2017

Financials

Next reporting dateMarch 2, 2018
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts